Skip to content
Disclosery

SYNOVUS FINANCIAL CORP: MRNA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of SYNOVUS FINANCIAL CORP on MRNA, newest first. How the timeline and the estimate are built.

SYNOVUS FINANCIAL CORP held 0 MRNA shares at 2024-09-30 per its 13F-HR/A filed 2024-11-25.

the latest 13F is the newest step

  1. period ended2024-09-30
    13F/A 0 shares
    Change vs previous 13F -2,068 shares

    13F-HR/A 0001172661-24-005359 filed by SYNOVUS FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-06-30
    13F 2,068 shares
    Change vs previous 13F -371 shares

    <0.01% of the 13F portfolio, value $245,577.

    13F-HR 0001172661-24-003333 filed by SYNOVUS FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-03-31
    13F 2,439 shares
    Change vs previous 13F -455 shares

    <0.01% of the 13F portfolio, value $259,900.

    13F-HR 0001172661-24-002277 filed by SYNOVUS FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2023-12-31
    13F 2,894 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $287,809.

    13F-HR 0001172661-24-000863 filed by SYNOVUS FINANCIAL CORP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).